1.Company Information

Established in 2007, Hamps Bio Limited specializes in the marketing and distribution of pharmaceutical products, including tablets, syrups, capsules, injectables, oils, and nutritional supplements. The company operates through a network of over 50 distributors and e-commerce platforms such as Amazon (US, Canada, EU), Flipkart, and Jio Mart. Its pharmaceutical products are available across eight states and union territories, while its freeze-dried and frozen offerings reach six countries and 22 states and union territories.
Hamps Bio's operations are divided into two key segments:

1. Pharmaceuticals:- The company markets its pharmaceutical range under the "Hamps" brand, offering tablets, syrups, capsules, injectables, and powders.
2. Freeze-dried and Frozen Products:- Its FMCG division, operating under the "FzyEzy" brand, focuses on freeze-dried and frozen items. Products include strawberry, jamun, mango, beet powder, chikoo powder, and more. This segment caters to both B2B and B2C customers, providing branded products and contract manufacturing services.
   The company offers a diverse portfolio of over 180 products across both segments. As of October 31, 2024, Hamps Bio employed 78 staff members.

Strenghts :-

1. Experienced Leadership and Strategic Industry Expertise Fueling Business Growth
2. Extensive Distribution Network with a Strong E-Commerce Presence
3. Comprehensive and Diverse Product Portfolio
4. Global Customer Base with Established Long-Term Relationships
5. Broad Geographical Reach
6. Strong Brand Recognition and Identity

2. Objects of the Issue (Hamps Bio Limited SME IPO Objectives)

The Company intends to use its proceeds as follows:
Purchase of plant & machinery for FMCG division
Enhancing the visibility and awareness of the brand
General corporate purposes

3. Hamps Bio Limited SME IPO Registrar

Bigshare Services Pvt Ltd

Phone: +91-22-6263 8200
Email: ipo@bigshareonline.com
Website: https://ipo.bigshareonline.com